India's AI Dialysis Ecosystem Offers Zero Capital Care

Lord's Mark Industries Ltd. has introduced a groundbreaking integrated dialysis ecosystem in Ahmedabad, powered by the AI-driven Renalyx Machine. This CE-certified, India-engineered system, alongside RenalOS and Aureoon, offers a unique Dialysis-as-a-Service model. It significantly reduces barriers by eliminating capital investment for hospitals, thereby enhancing the accessibility and affordability of advanced renal care.

The Renalyx Machine, part of a digital nephrology ecosystem, integrates intelligent automation with clinical workflows. RenalOS provides real-time AI monitoring, detecting early warning signs and ensuring care continuity through remote post-discharge monitoring. This shifts dialysis from an episodic treatment to a continuous, personalized, patient-first approach.

This development underscores India's growing prowess in medical technology manufacturing. Lord's Mark aims to establish 50 managed dialysis centers across India by March 2027, with plans for domestic sales and exports. The company is also seeking US FDA approval for the Renalyx Machine, reinforcing its global expansion ambitions.

Sachidanand Upadhyay, Managing Director, highlighted the commitment to positioning India as a global leader in AI-based medical device development. The integrated ecosystem aims to deliver high-quality treatment at scale, creating a globally competitive dialysis technology platform originating from India.